Nav: Home

Blood-repellent materials: A new approach to medical implants

January 18, 2017

FORT COLLINS, COLORADO - Medical implants like stents, catheters and tubing introduce risk for blood clotting and infection - a perpetual problem for many patients.

Colorado State University engineers offer a potential solution: A specially grown, "superhemophobic" titanium surface that's extremely repellent to blood. The material could form the basis for surgical implants with lower risk of rejection by the body.

It's an outside-the-box innovation achieved at the intersection of two disciplines: biomedical engineering and materials science. The work, recently published in Advanced Healthcare Materials, is a collaboration between the labs of Arun Kota, assistant professor of mechanical engineering and biomedical engineering; and Ketul Popat, associate professor in the same departments.

Kota, an expert in novel, "superomniphobic" materials that repel virtually any liquid, joined forces with Popat, an innovator in tissue engineering and bio-compatible materials. Starting with sheets of titanium, commonly used for medical devices, their labs grew chemically altered surfaces that act as perfect barriers between the titanium and blood. Their teams conducted experiments showing very low levels of platelet adhesion, a biological process that leads to blood clotting and eventual rejection of a foreign material.

A material "phobic" (repellent) to blood might seem counterintuitive, the researchers say, as often biomedical scientists use materials "philic" (with affinity) to blood to make them biologically compatible. "What we are doing is the exact opposite," Kota said. "We are taking a material that blood hates to come in contact with, in order to make it compatible with blood." The key innovation is that the surface is so repellent, that blood is tricked into believing there's virtually no foreign material there at all.

The undesirable interaction of blood with foreign materials is an ongoing problem in medical research, Popat said. Over time, stents can form clots, obstructions, and lead to heart attacks or embolisms. Often patients need blood-thinning medications for the rest of their lives - and the drugs aren't foolproof.

"The reason blood clots is because it finds cells in the blood to go to and attach," Popat said. "Normally, blood flows in vessels. If we can design materials where blood barely contacts the surface, there is virtually no chance of clotting, which is a coordinated set of events. Here, we're targeting the prevention of the first set of events."

The researchers analyzed variations of titanium surfaces, including different textures and chemistries, and they compared the extent of platelet adhesion and activation. Fluorinated nanotubes offered the best protection against clotting, and they plan to conduct follow-up experiments.

Growing a surface and testing it in the lab is only the beginning, the researchers say. They want to continue examining other clotting factors, and eventually, to test real medical devices.
-end-


Colorado State University

Related Biomedical Engineering Articles:

Artificial intelligence improves biomedical imaging
ETH researchers use artificial intelligence to improve quality of images recorded by a relatively new biomedical imaging method.
Researchers design superhydrophobic 'nanoflower' for biomedical applications
Plant leaves have a natural superpower -- they're designed with water repelling characteristics.
Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.
A pill for delivering biomedical micromotors
Using tiny micromotors to diagnose and treat disease in the human body could soon be a reality.
Accounting for sex differences in biomedical research
When it comes to health, a person's sex can play a role.
Biomedical Engineering hosts national conference on STEM education for underserved students
The University of Akron hosts a national conference aimed at ensuring underserved students have access to opportunities in science, technology, engineering and mathematics (STEM).
Boosting the lifetime and effectiveness of biomedical devices
A research team led by the University of Delaware's David Martin has discovered a new approach to boosting the lifetime and effectiveness of electronic biomedical devices.
Support for Chicago Biomedical Consortium renewed
The Searle Funds at The Chicago Community Trust has renewed its funding commitment to the Chicago Biomedical Consortium, a research and education collaboration of Northwestern University, the University of Illinois at Chicago and University of Chicago that has helped establish the Chicago area as a biomedical sciences leader.
Should biomedical graduate schools ignore the GRE?
A research team at the UNC School of Medicine found that the Graduate Record Exam (GRE), which is required for admission to graduate and doctorate programs across the country, is not the best indicator for predicting a student's success while pursuing a doctorate in the experimental life sciences.
HKU Engineering Professor Ron Hui named a Fellow by the UK Royal Academy of Engineering
Professor Ron Hui, Chair Professor of Power Electronics and Philip Wong Wilson Wong Professor of Electrical Engineering at the University of Hong Kong, has been named a Fellow by the Royal Academy of Engineering, UK, one of the most prestigious national academies.
More Biomedical Engineering News and Biomedical Engineering Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.